Task: Answer the multiple-choice question.
Query: Which drug has a -69.850% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CCCn1c(N2CCN(Cc3ccc(Cl)cc3)CC2)nc2ccccc21.Cl
b.) O=C(COC(=O)c1ccc([N+](=O)[O-])cc1Cl)Nc1cccnc1Cl
Answer: a. CCCn1c(N2CCN(Cc3ccc(Cl)cc3)CC2)nc2ccccc21.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(N2CCN(Cc3ccc(Cl)cc3)CC2)nc2ccccc21.Cl
CCCn1c(N2CCN(Cc3ccc(Cl)cc3)CC2)nc2ccccc21.Cl
2-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]-1-propylbenzimidazole;hydrochloride